Global Inhalation Anesthesia Market to Reach US$ 2.16 Billion by 2032, Propelled by Increasing Prevalence of Chronic Diseases

April 13, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Inhalation Anesthesia Market Report by Product (Desflurane, Sevoflurane, Isoflurane, and Others), Application (Induction, Maintenance), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032," the global inhalation anesthesia market size reached US$ 1.60 Billion in 2023. Inhalation anesthesia refers to a type of anesthetic that is administered in the lungs through an inhalation procedure. It can induce and maintain general anesthesia and sedation, due to which it is typically used during surgical procedures, especially when it is difficult to identify an intravenous route. Inhalation anesthesia includes enflurane, sevoflurane, desflurane, isoflurane, and volatile liquids, such as halothane, as standard drugs. These agents can cause a decrease in arterial blood pressure, respiratory depression, and an increase in cerebral blood flow, resulting in controlled pain and regulated breathing, blood pressure levels, blood flow, and heart rate and rhythm. As compared to traditionally used intravenous variants, inhalation anesthesia does not accumulate in the body and allows precise control over the sedative state of the patient at cost-effective rates. As a resuIt, inhalation anesthesia is extensively used in surgical centers and ambulatory and hospital settings by healthcare practitioners to numb the sensation in specific body parts and eliminate severe pain during surgical procedures. 

Global Inhalation Anesthesia Market Trends:

The increasing prevalence of chronic ailments, such as cardiovascular, gastrointestinal, neurological, respiratory, and degenerative disorders, and the rising instances of road accidents across the globe are primarily driving the market growth. In line with this, the shifting inclination towards minimally invasive (MI) treatments and the ongoing number of surgical procedures, such as laparoscopic, cosmetic surgery, and microsurgery, are acting as another growth-inducing factor. Additionally, the increasing instances of sports-related injuries and escalating frequencies of orthopedic operations, such as ligament and other soft tissue repair procedures, are further intensifying product usage in the healthcare sector. Moreover, the extensive use of sevoflurane and other ether-based inhalation anesthetic agents with low pungency and non-irritant odor in ambulatory healthcare centers for patients dealing with asthma or sensitive air passages is impelling the market growth. Furthermore, the recent development of anesthesia recycling systems for isolating anesthetic compounds from hospital vents and operating rooms is favoring the market growth. Apart from this, the introduction of novel product variants with enhanced compatibility and minimal side effects to promote the effective treatment of patients sensitive to anesthetic agents is positively impacting the market growth. Looking forward, the market value is projected to reach US$ 2.16 Billion by 2032, expanding at a CAGR of 3.1% during 2024-2032. 

Market Summary:

  • On the basis of the product type, the market is segregated into desflurane, sevoflurane, isoflurane, and others.
  • Based on the application, the market has been bifurcated into induction and maintenance.
  • On the basis of the end user, the market has been divided into hospitals, ambulatory surgical centers, and others.
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd, Merck KGaA, Piramal Enterprises Ltd. and Troikaa Pharmaceuticals Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd, Merck KGaA, Piramal Enterprises Ltd. and Troikaa Pharmaceuticals Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Inhalation Anesthesia Market to Reach US$ 2.16 Billion by 2032, Propelled by Increasing Prevalence of Chronic Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More